Adapthealth Cost Of Revenue vs Capex To Revenue Analysis

AHCO Stock

USD 9.64 0.06 0.62%

Adapthealth Corp financial indicator trend analysis is way more than just evaluating Adapthealth Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adapthealth Corp is a good investment. Please check the relationship between Adapthealth Corp Cost Of Revenue and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adapthealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Adapthealth Stock, please use our How to Invest in Adapthealth Corp guide.

Cost Of Revenue vs Capex To Revenue

Cost Of Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adapthealth Corp Cost Of Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Adapthealth Corp's Cost Of Revenue and Capex To Revenue is 0.84. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Adapthealth Corp, assuming nothing else is changed. The correlation between historical values of Adapthealth Corp's Cost Of Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Adapthealth Corp are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Cost Of Revenue i.e., Adapthealth Corp's Cost Of Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.84

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Adapthealth Corp income statement and represents the costs associated with goods and services Adapthealth Corp provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Adapthealth Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adapthealth Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adapthealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Adapthealth Stock, please use our How to Invest in Adapthealth Corp guide.As of the 5th of January 2025, Selling General Administrative is likely to grow to about 229.5 M, while Discontinued Operations is likely to drop (249.5 K).

	2022	2023	2024	2025 (projected)
Gross Profit	417.4M	479.6M	551.5M	579.1M
Total Revenue	3.0B	3.2B	3.7B	3.9B

Gross Profit Total Revenue

Adapthealth Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Inventory	Other Stockholder Equity	Total Liab	Net Invested Capital	Short Long Term Debt
Total Assets		0.99	0.81	0.96	0.99	0.95	-0.98	0.94	-0.59	0.97	0.85	1.0	-0.03	0.94	1.0	0.85	0.93	1.0	-0.16	0.99	0.94	1.0	0.94	0.95	0.86	0.81
Short Long Term Debt Total	0.99		0.83	0.95	0.97	0.95	-0.98	0.96	-0.66	0.96	0.83	0.99	0.03	0.94	1.0	0.83	0.95	0.98	-0.1	0.98	0.95	0.99	0.95	0.96	0.89	0.85
Other Current Liab	0.81	0.83		0.91	0.73	0.92	-0.87	0.88	-0.79	0.9	0.83	0.79	-0.07	0.94	0.82	0.83	0.91	0.77	-0.2	0.78	0.87	0.84	0.87	0.91	0.92	0.86
Total Current Liabilities	0.96	0.95	0.91		0.9	0.94	-0.95	0.91	-0.67	0.99	0.9	0.95	-0.07	0.95	0.96	0.9	0.92	0.93	-0.2	0.93	0.9	0.97	0.9	0.93	0.87	0.81
Total Stockholder Equity	0.99	0.97	0.73	0.9		0.92	-0.96	0.92	-0.49	0.92	0.8	0.99	0.02	0.9	0.97	0.8	0.9	0.99	-0.1	0.97	0.92	0.97	0.92	0.92	0.81	0.77
Other Liab	0.95	0.95	0.92	0.94	0.92		-0.98	0.99	-0.72	0.95	0.86	0.94	-0.06	1.0	0.95	0.86	0.99	0.94	-0.2	0.93	0.99	0.95	0.99	1.0	0.95	0.9
Net Tangible Assets	-0.98	-0.98	-0.87	-0.95	-0.96	-0.98		-0.98	0.66	-0.96	-0.86	-0.98	0.04	-0.97	-0.98	-0.86	-0.97	-0.97	0.17	-0.95	-0.97	-0.98	-0.97	-0.98	-0.91	-0.86
Net Debt	0.94	0.96	0.88	0.91	0.92	0.99	-0.98		-0.74	0.91	0.8	0.94	-0.06	0.98	0.95	0.8	1.0	0.94	-0.19	0.94	1.0	0.95	1.0	1.0	0.96	0.93
Retained Earnings	-0.59	-0.66	-0.79	-0.67	-0.49	-0.72	0.66	-0.74		-0.59	-0.5	-0.58	0.05	-0.71	-0.64	-0.5	-0.77	-0.54	0.14	-0.64	-0.74	-0.61	-0.74	-0.73	-0.88	-0.9
Accounts Payable	0.97	0.96	0.9	0.99	0.92	0.95	-0.96	0.91	-0.59		0.92	0.96	-0.07	0.96	0.96	0.92	0.91	0.95	-0.2	0.93	0.9	0.98	0.9	0.94	0.85	0.77
Cash	0.85	0.83	0.83	0.9	0.8	0.86	-0.86	0.8	-0.5	0.92		0.84	-0.06	0.87	0.84	1.0	0.8	0.83	-0.18	0.79	0.79	0.86	0.79	0.83	0.73	0.61
Non Current Assets Total	1.0	0.99	0.79	0.95	0.99	0.94	-0.98	0.94	-0.58	0.96	0.84		-0.03	0.93	0.99	0.84	0.93	1.0	-0.15	0.99	0.94	1.0	0.94	0.94	0.85	0.81
Non Currrent Assets Other	-0.03	0.03	-0.07	-0.07	0.02	-0.06	0.04	-0.06	0.05	-0.07	-0.06	-0.03		-0.05	-0.05	-0.06	-0.02	-0.03	0.99	-0.05	-0.06	-0.05	-0.06	-0.06	-0.02	0.02
Other Assets	0.94	0.94	0.94	0.95	0.9	1.0	-0.97	0.98	-0.71	0.96	0.87	0.93	-0.05		0.94	0.87	0.98	0.92	-0.18	0.91	0.97	0.95	0.97	0.99	0.95	0.89
Long Term Debt	1.0	1.0	0.82	0.96	0.97	0.95	-0.98	0.95	-0.64	0.96	0.84	0.99	-0.05	0.94		0.84	0.93	0.99	-0.17	0.99	0.94	1.0	0.94	0.95	0.88	0.83
Cash And Short Term Investments	0.85	0.83	0.83	0.9	0.8	0.86	-0.86	0.8	-0.5	0.92	1.0	0.84	-0.06	0.87	0.84		0.8	0.83	-0.18	0.79	0.79	0.86	0.79	0.83	0.73	0.61
Net Receivables	0.93	0.95	0.91	0.92	0.9	0.99	-0.97	1.0	-0.77	0.91	0.8	0.93	-0.02	0.98	0.93	0.8		0.92	-0.15	0.93	1.0	0.93	1.0	1.0	0.98	0.95
Good Will	1.0	0.98	0.77	0.93	0.99	0.94	-0.97	0.94	-0.54	0.95	0.83	1.0	-0.03	0.92	0.99	0.83	0.92		-0.15	0.98	0.94	0.99	0.94	0.94	0.83	0.79
Common Stock Total Equity	-0.16	-0.1	-0.2	-0.2	-0.1	-0.2	0.17	-0.19	0.14	-0.2	-0.18	-0.15	0.99	-0.18	-0.17	-0.18	-0.15	-0.15		-0.17	-0.18	-0.18	-0.19	-0.19	-0.15	-0.09
Common Stock Shares Outstanding	0.99	0.98	0.78	0.93	0.97	0.93	-0.95	0.94	-0.64	0.93	0.79	0.99	-0.05	0.91	0.99	0.79	0.93	0.98	-0.17		0.94	0.98	0.94	0.93	0.87	0.84
Capital Surpluse	0.94	0.95	0.87	0.9	0.92	0.99	-0.97	1.0	-0.74	0.9	0.79	0.94	-0.06	0.97	0.94	0.79	1.0	0.94	-0.18	0.94		0.94	1.0	0.99	0.96	0.94
Inventory	1.0	0.99	0.84	0.97	0.97	0.95	-0.98	0.95	-0.61	0.98	0.86	1.0	-0.05	0.95	1.0	0.86	0.93	0.99	-0.18	0.98	0.94		0.94	0.95	0.87	0.82
Other Stockholder Equity	0.94	0.95	0.87	0.9	0.92	0.99	-0.97	1.0	-0.74	0.9	0.79	0.94	-0.06	0.97	0.94	0.79	1.0	0.94	-0.19	0.94	1.0	0.94		0.99	0.96	0.94
Total Liab	0.95	0.96	0.91	0.93	0.92	1.0	-0.98	1.0	-0.73	0.94	0.83	0.94	-0.06	0.99	0.95	0.83	1.0	0.94	-0.19	0.93	0.99	0.95	0.99		0.96	0.92
Net Invested Capital	0.86	0.89	0.92	0.87	0.81	0.95	-0.91	0.96	-0.88	0.85	0.73	0.85	-0.02	0.95	0.88	0.73	0.98	0.83	-0.15	0.87	0.96	0.87	0.96	0.96		0.98
Short Long Term Debt	0.81	0.85	0.86	0.81	0.77	0.9	-0.86	0.93	-0.9	0.77	0.61	0.81	0.02	0.89	0.83	0.61	0.95	0.79	-0.09	0.84	0.94	0.82	0.94	0.92	0.98

Click cells to compare fundamentals

Adapthealth Corp Account Relationship Matchups

Adapthealth Corp fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.8B	5.3B	5.2B	4.5B	5.2B	2.7B
Short Long Term Debt Total	807.0M	2.4B	2.3B	2.3B	2.6B	1.5B
Other Current Liab	174.0M	102.4M	98.3M	156.8M	180.3M	189.3M
Total Current Liabilities	434.8M	499.8M	456.2M	537.0M	617.5M	311.4M
Total Stockholder Equity	394.8M	2.1B	2.2B	1.5B	1.7B	982.1M
Other Liab	29.3M	209.0M	380.3M	344.0M	395.6M	415.4M
Net Tangible Assets	(290.2M)	(696.5M)	(1.6B)	(1.6B)	(1.4B)	(1.3B)
Net Debt	707.0M	2.2B	2.3B	2.2B	2.6B	2.7B
Retained Earnings	(91.1M)	(43.0M)	26.3M	(652.6M)	(587.3M)	(558.0M)
Accounts Payable	191.0M	248.0M	222.5M	211.5M	243.2M	141.4M
Cash	100.0M	149.6M	46.3M	77.1M	88.7M	60.3M
Non Current Assets Total	1.5B	4.6B	4.6B	3.9B	4.4B	2.3B
Non Currrent Assets Other	16.5M	15.1M	18.7M	20.1M	18.1M	17.2M
Other Assets	34.8M	224.9M	319.3M	300.5M	345.5M	362.8M
Long Term Debt	776.6M	2.2B	2.2B	2.1B	2.4B	1.2B
Cash And Short Term Investments	100.0M	149.6M	46.3M	77.1M	88.7M	60.3M
Net Receivables	171.1M	359.9M	359.1M	388.9M	447.2M	469.6M
Good Will	1.0B	3.5B	3.5B	2.7B	3.1B	1.7B
Common Stock Total Equity	240.6M	7.2K	9K	13K	11.7K	11.1K
Common Stock Shares Outstanding	52.5M	133.0M	139.0M	134.4M	154.6M	85.5M
Liabilities And Stockholders Equity	1.8B	5.3B	5.2B	4.5B	5.2B	2.7B
Non Current Liabilities Total	996.7M	2.7B	2.6B	2.5B	2.9B	3.0B
Capital Surpluse	2.9M	11.3M	558.5M	2.1B	2.4B	2.5B
Inventory	58.8M	123.1M	127.8M	113.6M	130.7M	71.4M
Other Stockholder Equity	558.5M	2.1B	2.1B	2.1B	2.4B	2.5B
Total Liab	1.4B	3.2B	3.1B	3.0B	3.5B	3.7B
Net Invested Capital	1.2B	2.2B	2.2B	3.6B	4.1B	4.4B
Short Long Term Debt	8.1M	20M	35M	53.4M	61.4M	64.4M
Total Current Assets	372.8M	670.1M	585.3M	649.0M	746.4M	783.7M
Net Working Capital	(58.8M)	170.2M	129.1M	112.0M	128.8M	135.3M
Short Term Debt	52.7M	113.7M	99.4M	130.2M	149.7M	157.2M
Common Stock	240.6M	7.2K	9K	13K	11.7K	11.1K
Property Plant Equipment	63.6M	110.5M	546.3M	622.0M	715.3M	751.1M
Other Current Assets	33.4M	74.9M	52.1M	69.3M	79.7M	42.7M
Property Plant And Equipment Net	110.5M	546.3M	622.0M	637.5M	733.2M	422.1M
Current Deferred Revenue	11.0M	31.4M	31.6M	38.6M	44.4M	25.1M
Capital Lease Obligations	22.3M	167.0M	140.6M	146.7M	168.7M	109.2M

Pair Trading with Adapthealth Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adapthealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adapthealth Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against Adapthealth Stock

0.68	GH	Guardant Health	Pair Corr
0.68	OM	Outset Medical Earnings Call Tomorrow	Pair Corr
0.67	ELMD	Electromed	Pair Corr
0.58	VREX	Varex Imaging Corp	Pair Corr
0.57	DXCM	DexCom Inc	Pair Corr

The ability to find closely correlated positions to Adapthealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adapthealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adapthealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adapthealth Corp to buy it.

The correlation of Adapthealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adapthealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adapthealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Adapthealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Adapthealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Adapthealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adapthealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adapthealth Corp Stock:

How To Invest In Adapthealth

Details

Is Adapthealth Stock a good investment?

Details

What is Adapthealth Corp's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adapthealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Adapthealth Stock, please use our How to Invest in Adapthealth Corp guide.

You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adapthealth Corp. If investors know Adapthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adapthealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.444

Earnings Share

(1.67)

Revenue Per Share

24.465

Quarterly Revenue Growth

0.002

Return On Assets

0.0411

The market value of Adapthealth Corp is measured differently than its book value, which is the value of Adapthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Adapthealth Corp's value that differs from its market value or its book value, called intrinsic value, which is Adapthealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adapthealth Corp's market value can be influenced by many factors that don't directly affect Adapthealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adapthealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adapthealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adapthealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Adapthealth Cost Of Revenue vs Capex To Revenue Analysis

Cost Of Revenue vs Capex To Revenue

Cost Of Revenue vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Capex To Revenue

Adapthealth Corp fundamental ratios Correlations

Adapthealth Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Adapthealth Corp fundamental ratios Accounts

Pair Trading with Adapthealth Corp

Moving against Adapthealth Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Total Assets
Good Will	+ 1.0	Total Assets
Inventory	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Short Long Term Debt Total
Other Assets	+ 1.0	Other Liab

Total Liab	- 0.98	Net Tangible Assets
Inventory	- 0.98	Net Tangible Assets
Long Term Debt	- 0.98	Net Tangible Assets
Non Current Assets Total	- 0.98	Net Tangible Assets
Net Debt	- 0.98	Net Tangible Assets
Net Tangible Assets	- 0.98	Other Liab